Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20220170
    Release date: 13 April 2023

    Promoter – Financial Intermediary

    DEK VACCINES LTD

    Location

    Description

    The project consists in a grant facility of up to EUR 5m providing seed financing to support the construction, furnishing and validation of a fill and finish vaccine manufacturing facility in the suburbs of Accra, Ghana.

    Objectives

    The facility will initially target vaccines that are a priority for the African continent and is expected to contribute to enhanced regional independence in health security.

    Sector(s)

    Proposed EIB finance (Approximate amount)

    EUR 5 million

    Total cost (Approximate amount)

    EUR 47 million

    Environmental aspects

    The promoter is required to implement the project in accordance with the EIB's Environmental and Social Policy and Standards.

    Procurement

    The promoter is required to implement the project in accordance with the EIB's Guide to Procurement.

    Status

    Signed - 29/03/2023

    Milestone
    Under appraisal
    Approved
    Signed
    27 March 2023
    29 March 2023

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Regional - West Africa Industry